Is BLCYT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BLCYT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BLCYT (TRY17.7) is trading above our estimate of fair value (TRY8.17)
Significantly Below Fair Value: BLCYT is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BLCYT?
Key metric: As BLCYT is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for BLCYT. This is calculated by dividing BLCYT's market cap by their current
earnings.
What is BLCYT's PE Ratio?
PE Ratio
25x
Earnings
₺70.86m
Market Cap
₺1.77b
BLCYT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
ARSAN Arsan Tekstil Ticaret ve Sanayi Anonim Sirketi
4.2x
n/a
US$139.77m
MNDRS Menderes Tekstil Sanayi ve Ticaret Anonim Sirketi
4.1x
n/a
US$88.69m
No more companies available in this PE range
2 Companies
Estimated Growth
Market Cap
No more companies
Price-To-Earnings vs Industry: BLCYT is expensive based on its Price-To-Earnings Ratio (25x) compared to the TR Luxury industry average (23.7x).
Price to Earnings Ratio vs Fair Ratio
What is BLCYT's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
BLCYT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
25x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BLCYT's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.